Dejana Braithwaite

Dejana Braithwaite,

Professor

Department: MD-AGING/ GERIATRIC RES-OTHER
Business Phone: (352) 273-5468
Business Email: dbraithwaite@ufl.edu

Accomplishments

Inductee
2017 · Royal Society of Medicine (UK)
Member, Expert Panel
2015 · National Academy of Sciences, Institute of Medicine, National Cancer Policy Forum
Mentored Research Scholar Award
2012-2017 · American Cancer Society
Career Catalyst Award
2011-2014 · Susan Komen Foundation
Junior Investigator Award
2011 · National Center of Excellence in Women’s Health, University of California, San Francisco
Junior Investigator Award
2010 · Academic Senate, University of California, San Francisco
Developmental Award
2009 · NIH Bay Area Breast Cancer Specialized Program of Research Excellence (SPORE)
Hellman Foundation Award for Early Career Faculty
2009 · University of California, San Francisco
Cancer Prevention Research Fellowship (1 awarded nationally in the United States)
2007 · Prevent Cancer Foundation/American Society for Preventive Oncology
Scholar-in-Training Award
2003 · American Association for Cancer Research, Frontiers in Cancer Prevention
Pre-doctoral Fellowship (2 awarded nationally in the United Kingdom)
2000 · Cancer Research U.K.

Publications

2021
Immunotherapy Utilization Among Patients With Metastatic NSCLC: Impact of Comorbidities.
Journal of immunotherapy (Hagerstown, Md. : 1997). 44(5):198-203 [DOI] 10.1097/CJI.0000000000000366. [PMID] 33758148.
2021
Self-rated health in relation to fruit and vegetable consumption and physical activity among older cancer survivors.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 29(5):2713-2722 [DOI] 10.1007/s00520-020-05782-6. [PMID] 32979089.
2021
Spatial, temporal, and demographic patterns in prevalence of chewing tobacco use in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019.
The Lancet. Public health. [DOI] 10.1016/S2468-2667(21)00065-7. [PMID] 34051920.
2021
Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990-2019: a systematic analysis from the Global Burden of Disease Study 2019.
Lancet (London, England). [DOI] 10.1016/S0140-6736(21)01169-7. [PMID] 34051883.
2021
The association between cognitive impairment and breast and colorectal cancer screening utilization.
BMC cancer. 21(1) [DOI] 10.1186/s12885-021-08321-6. [PMID] 33975576.
2020
Author Correction: Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017.
Nature medicine. 26(8) [DOI] 10.1038/s41591-020-0972-7. [PMID] 32616917.
2020
Cervical neoplastic lesions in relation to CD4 T-lymphocyte counts and antiretroviral therapy among women with clinical stage 1 HIV in Yunnan, China.
The Kaohsiung journal of medical sciences. 36(6):450-459 [DOI] 10.1002/kjm2.12175. [PMID] 31913555.
2020
Epidemiology and Molecular-Pathologic Characteristics of CpG Island Methylator Phenotype (CIMP) in Colorectal Cancer.
Clinical colorectal cancer. [DOI] 10.1016/j.clcc.2020.09.007. [PMID] 33229221.
2020
Estimating global injuries morbidity and mortality: methods and data used in the Global Burden of Disease 2017 study.
Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention. 26(Supp 1):i125-i153 [DOI] 10.1136/injuryprev-2019-043531. [PMID] 32839249.
2020
Five insights from the Global Burden of Disease Study 2019.
Lancet (London, England). 396(10258):1135-1159 [DOI] 10.1016/S0140-6736(20)31404-5. [PMID] 33069324.
2020
Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019.
Lancet (London, England). 396(10258):1160-1203 [DOI] 10.1016/S0140-6736(20)30977-6. [PMID] 33069325.
2020
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019.
Lancet (London, England). 396(10258):1223-1249 [DOI] 10.1016/S0140-6736(20)30752-2. [PMID] 33069327.
2020
Impact of healthcare access and HIV testing on utilisation of cervical cancer screening among US women at high risk of HIV infection: cross-sectional analysis of 2016 BRFSS data.
BMJ open. 10(1) [DOI] 10.1136/bmjopen-2019-031823. [PMID] 31911515.
2020
Is education or income associated with insufficient fruit and vegetable intake among cancer survivors? A cross-sectional analysis of 2017 BRFSS data.
BMJ open. 10(12) [DOI] 10.1136/bmjopen-2020-041285. [PMID] 33262193.
2020
Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017.
Nature medicine. 26(5):750-759 [DOI] 10.1038/s41591-020-0807-6. [PMID] 32313249.
2020
Mobile Technologies and Cervical Cancer Screening in Low- and Middle-Income Countries: A Systematic Review.
JCO global oncology. 6:617-627 [DOI] 10.1200/JGO.19.00201. [PMID] 32302236.
2020
Screening Mammography Outcomes: Risk of Breast Cancer and Mortality by Comorbidity Score and Age.
Journal of the National Cancer Institute. 112(6):599-606 [DOI] 10.1093/jnci/djz172. [PMID] 31593591.
2020
The global, regional, and national burden of stomach cancer in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease study 2017.
The lancet. Gastroenterology & hepatology. 5(1):42-54 [DOI] 10.1016/S2468-1253(19)30328-0. [PMID] 31648970.
2019
Chronic inflammation and risk of lung cancer in older adults in the health, aging and body composition cohort study.
Journal of geriatric oncology. 10(2):265-271 [DOI] 10.1016/j.jgo.2018.07.008. [PMID] 30078713.
2019
Global differences in the prevalence of the CpG island methylator phenotype of colorectal cancer.
BMC cancer. 19(1) [DOI] 10.1186/s12885-019-6144-9. [PMID] 31623592.
2019
Metabolic syndrome and risk of breast cancer mortality by menopause, obesity, and subtype.
Breast cancer research and treatment. 174(1):209-218 [DOI] 10.1007/s10549-018-5056-8. [PMID] 30465158.
2019
Optimizing selection of candidates for lung cancer screening: role of comorbidity, frailty and life expectancy.
Translational lung cancer research. 8(Suppl 4):S454-S459 [DOI] 10.21037/tlcr.2019.10.03. [PMID] 32038937.
2019
Smoking cessation interventions for potential use in the lung cancer screening setting: A systematic review and meta-analysis.
Lung cancer (Amsterdam, Netherlands). 135:205-216 [DOI] 10.1016/j.lungcan.2019.06.024. [PMID] 31446996.
2019
Socioeconomic gradients in cancer incidence by race and ethnicity in California, 2008-2012: the influence of tobacco use or screening detectable cancers.
Cancer causes & control : CCC. 30(7):697-706 [DOI] 10.1007/s10552-019-01172-4. [PMID] 31065915.
2018
Family History and Breast Cancer Risk Among Older Women in the Breast Cancer Surveillance Consortium Cohort.
JAMA internal medicine. 178(4):494-501 [DOI] 10.1001/jamainternmed.2017.8642. [PMID] 29435563.
2018
Metabolic Syndrome and the Risk of Breast Cancer and Subtypes by Race, Menopause and BMI.
Cancers. 10(9) [DOI] 10.3390/cancers10090299. [PMID] 30200454.
2018
Screening mammography use in older women according to health status: a systematic review and meta-analysis.
Clinical interventions in aging. 13:1987-1997 [DOI] 10.2147/CIA.S171739. [PMID] 30349218.
2018
The association of early life socioeconomic position on breast cancer incidence and mortality: a systematic review.
International journal of public health. 63(7):787-797 [DOI] 10.1007/s00038-017-1060-8. [PMID] 29197969.
2017
Childhood Socioeconomic Position and Pubertal Onset in a Cohort of Multiethnic Girls: Implications for Breast Cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 26(12):1714-1721 [DOI] 10.1158/1055-9965.EPI-17-0496. [PMID] 28939588.
2017
Emerging Trends in Family History of Breast Cancer and Associated Risk.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 26(12):1753-1760 [DOI] 10.1158/1055-9965.EPI-17-0531. [PMID] 28986348.
2017
Family History of Breast Cancer, Breast Density, and Breast Cancer Risk in a U.S. Breast Cancer Screening Population.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 26(6):938-944 [DOI] 10.1158/1055-9965.EPI-16-0801. [PMID] 28096200.
2017
Lifecourse socioeconomic status and cancer-related risk factors: Analysis of the WHO study on global ageing and adult health (SAGE).
International journal of cancer. 140(4):777-787 [DOI] 10.1002/ijc.30499. [PMID] 27813060.
2017
Socio-economic status over the life course and obesity: Systematic review and meta-analysis.
PloS one. 12(5) [DOI] 10.1371/journal.pone.0177151. [PMID] 28510579.
2016
Alcohol consumption and mortality after breast cancer diagnosis: The health and functioning in women study.
Breast disease. 36(2-3):77-89 [DOI] 10.3233/BD-150202. [PMID] 27662274.
2016
Benefits and Harms of Screening Mammography by Comorbidity and Age: A Qualitative Synthesis of Observational Studies and Decision Analyses.
Journal of general internal medicine. 31(5):561-72 [DOI] 10.1007/s11606-015-3580-3. [PMID] 26831305.
2016
Chronic inflammation and risk of colorectal and other obesity-related cancers: The health, aging and body composition study.
International journal of cancer. 138(5):1118-28 [DOI] 10.1002/ijc.29868. [PMID] 26413860.
2016
Life-course socioeconomic status and breast and cervical cancer screening: analysis of the WHO’s Study on Global Ageing and Adult Health (SAGE).
BMJ open. 6(11) [DOI] 10.1136/bmjopen-2016-012753. [PMID] 27881528.
2016
Multilevel factors associated with long-term adherence to screening mammography in older women in the U.S.
Preventive medicine. 89:169-177 [DOI] 10.1016/j.ypmed.2016.05.034. [PMID] 27261409.
2016
Optimal breast cancer screening strategies for older women: current perspectives.
Clinical interventions in aging. 11:111-25 [DOI] 10.2147/CIA.S65304. [PMID] 26893548.
2016
Utilization of screening mammography in older women according to comorbidity and age: protocol for a systematic review.
Systematic reviews. 5(1) [PMID] 27716433.
View on: PubMed
2015
Performance of digital screening mammography among older women in the United States.
Cancer. 121(9):1379-86 [DOI] 10.1002/cncr.29214. [PMID] 25537958.
2015
Smoking and mortality after breast cancer diagnosis: the health and functioning in women study.
Cancer medicine. 4(2):315-24 [DOI] 10.1002/cam4.359. [PMID] 25511535.
2014
A multilevel model of postmenopausal breast cancer incidence.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 23(10):2078-92 [DOI] 10.1158/1055-9965.EPI-14-0403. [PMID] 25017248.
2014
Challenges and opportunities in international molecular cancer prevention research: An ASPO Molecular Epidemiology and the Environment and International Cancer Prevention Interest Groups Report.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 23(11):2613-7 [DOI] 10.1158/1055-9965.EPI-14-0848. [PMID] 25277796.
2014
Long-term outcomes among African-American and white women with breast cancer: what is the impact of comorbidity?
Journal of geriatric oncology. 5(3):266-75 [DOI] 10.1016/j.jgo.2014.02.003. [PMID] 24613574.
2013
Impact of mammography screening interval on breast cancer diagnosis by menopausal status and BMI.
Journal of general internal medicine. 28(11):1454-62 [DOI] 10.1007/s11606-013-2507-0. [PMID] 23760741.
2013
Mammographic screening interval in relation to tumor characteristics and false-positive risk by race/ethnicity and age.
Cancer. 119(22):3959-67 [DOI] 10.1002/cncr.28310. [PMID] 24037812.
2013
Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy.
JAMA internal medicine. 173(9):807-16 [DOI] 10.1001/jamainternmed.2013.307. [PMID] 23552817.
2013
Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?
Journal of the National Cancer Institute. 105(5):334-41 [DOI] 10.1093/jnci/djs645. [PMID] 23385442.
2013
The impact of functional limitations on long-term outcomes among African-American and white women with breast cancer: a cohort study.
BMJ open. 3(10) [DOI] 10.1136/bmjopen-2013-003232. [PMID] 24114369.
2013
To screen or not to screen older women for breast cancer: a conundrum.
Future oncology (London, England). 9(6):763-6 [DOI] 10.2217/fon.13.64. [PMID] 23718292.
2013
Undertaking cancer research in international settings: report from the american society for preventive oncology special interest group on international issues in cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 22(9):1638-41 [DOI] 10.1158/1055-9965.EPI-13-0655. [PMID] 23845714.
2012
Cancer prevention for global health: a report from the ASPO International Cancer Prevention Interest Group.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 21(9):1606-10 [DOI] 10.1158/1055-9965.EPI-12-0848. [PMID] 22850804.
2012
Prognostic impact of comorbidity among long-term breast cancer survivors: results from the LACE study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 21(7):1115-25 [DOI] 10.1158/1055-9965.EPI-11-1228. [PMID] 22573797.
2012
Smoking and survival after breast cancer diagnosis: a prospective observational study and systematic review.
Breast cancer research and treatment. 136(2):521-33 [DOI] 10.1007/s10549-012-2276-1. [PMID] 23053660.
2011
The relative importance of predictors of body mass index change, overweight and obesity in adolescent girls.
International journal of pediatric obesity : IJPO : an official journal of the International Association for the Study of Obesity. 6(2-2):e233-42 [DOI] 10.3109/17477166.2010.545410. [PMID] 21244233.
2010
Long-term prognostic role of functional limitations among women with breast cancer.
Journal of the National Cancer Institute. 102(19):1468-77 [DOI] 10.1093/jnci/djq344. [PMID] 20861456.
2010
Opportunities for cancer epidemiology and control in low- and middle-income countries: a report from the american society for preventive oncology international cancer prevention interest group.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. 19(7):1665-7 [DOI] 10.1158/1055-9965.EPI-10-0523. [PMID] 20615883.
2010
Pre-counseling education for low literacy women at risk of Hereditary Breast and Ovarian Cancer (HBOC): patient experiences using the Cancer Risk Education Intervention Tool (CREdIT).
Journal of genetic counseling. 19(5):447-62 [DOI] 10.1007/s10897-010-9303-3. [PMID] 20490636.
2009
Hypertension is an independent predictor of survival disparity between African-American and white breast cancer patients.
International journal of cancer. 124(5):1213-9 [DOI] 10.1002/ijc.24054. [PMID] 19058216.
2009
Socioeconomic status in relation to early menarche among black and white girls.
Cancer causes & control : CCC. 20(5):713-20 [DOI] 10.1007/s10552-008-9284-9. [PMID] 19107561.
2005
Development of a risk assessment tool for women with a family history of breast cancer.
Cancer detection and prevention. 29(5):433-9 [PMID] 16055276.
View on: PubMed

Grants

Jan 2020 ACTIVE
The benefits and harms of lung cancer screening in Florida
Role: Co-Investigator
Funding: NATL INST OF HLTH NCI

Education

Fellow, Epidemiology and Public Health
2017-2021 · Royal Society of Medicine
Cancer Prevention Fellow
2006-2008 · American Society of Preventive Oncology/Prevent Cancer Foundation
Postdoctoral Fellow, Center for Health and Community
2006-2007 · University of California, San Francisco
Postdoctoral Fellow in Cancer Epidemiology
2004-2007 · Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco
Postdoctoral Fellow in Health Services Research, Institute for Health Policy Studies
2004-2006 · University of California, San Francisco
Fellow in Health Outcomes Research
2000-2004 · Institute of Public Health, University of Cambridge, England and Cancer Research
Ph.D., Epidemiology
2000-2004 · University of Cambridge, Institute of Public Health, Faculty of Clinical Medicine, England
M.Sc. (high honors), Public Health/Health Psychology
1998-1999 · University College London/Kings College, England
B.Sc. (high honors), Psychology and Psychobiology
1995-1998 · London Guildhall University, England

Contact Details

Phones:
Business:
(352) 273-5468
Emails: